Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Pollen grains as a novel microcarrier for oral delivery of proteins.

Lale SV, Gill HS.

Int J Pharm. 2018 Dec 1;552(1-2):352-359. doi: 10.1016/j.ijpharm.2018.10.016. Epub 2018 Oct 9.

PMID:
30308271
2.

Eudragit® L100-coated mannosylated chitosan nanoparticles for oral protein vaccine delivery.

Xu B, Zhang W, Chen Y, Xu Y, Wang B, Zong L.

Int J Biol Macromol. 2018 Jul 1;113:534-542. doi: 10.1016/j.ijbiomac.2018.02.016. Epub 2018 Feb 3.

PMID:
29408613
3.

A laminated polymer film formulation for enteric delivery of live vaccine and probiotic bacteria.

de Barros JMS, Scherer T, Charalampopoulos D, Khutoryanskiy VV, Edwards AD.

J Pharm Sci. 2014 Jul;103(7):2022-2032. doi: 10.1002/jps.23997. Epub 2014 May 6.

PMID:
24801679
4.

Ragweed pollen as an oral vaccine delivery system: Mechanistic insights.

Uddin MJ, Gill HS.

J Control Release. 2017 Dec 28;268:416-426. doi: 10.1016/j.jconrel.2017.10.019. Epub 2017 Oct 17.

5.

Influence of lidocaine forms (salt vs. freebase) on properties of drug-eudragit® L100-55 extrudates prepared by reactive melt extrusion.

Liu X, Ma X, Kun E, Guo X, Yu Z, Zhang F.

Int J Pharm. 2018 Aug 25;547(1-2):291-302. doi: 10.1016/j.ijpharm.2018.06.009. Epub 2018 Jun 5.

PMID:
29883791
6.

Implementation of mixture design for formulation of albumin containing enteric-coated spray-dried microparticles.

Shastri PN, Ubale RV, D'Souza MJ.

Drug Dev Ind Pharm. 2013 Feb;39(2):164-75. doi: 10.3109/03639045.2012.664148. Epub 2012 May 17.

PMID:
22591196
7.

Development of enteric-coated fixed dose combinations of amorphous solid dispersions of ezetimibe and lovastatin: Investigation of formulation and process parameters.

Riekes MK, Dereymaker A, Berben P, Augustijns P, Stulzer HK, Van den Mooter G.

Int J Pharm. 2017 Mar 30;520(1-2):49-58. doi: 10.1016/j.ijpharm.2017.01.053. Epub 2017 Jan 30.

PMID:
28153650
8.

Mechanistic understanding of ragweed pollen for oral vaccine delivery.

Park K.

J Control Release. 2017 Dec 28;268:427. doi: 10.1016/j.jconrel.2017.11.038. Review. No abstract available.

PMID:
29217275
9.

Colon-targeted delivery of solubilized bisacodyl by doubly enteric-coated multiple-unit tablet.

Park HJ, Jung HJ, Ho MJ, Lee DR, Cho HR, Choi YS, Jun J, Son M, Kang MJ.

Eur J Pharm Sci. 2017 May 1;102:172-179. doi: 10.1016/j.ejps.2017.03.006. Epub 2017 Mar 6.

PMID:
28279763
10.

Comparative evaluation of interpolyelectrolyte complexes of chitosan with Eudragit L100 and Eudragit L100-55 as potential carriers for oral controlled drug delivery.

Moustafine RI, Margulis EB, Sibgatullina LF, Kemenova VA, Van den Mooter G.

Eur J Pharm Biopharm. 2008 Sep;70(1):215-25. doi: 10.1016/j.ejpb.2008.04.008. Epub 2008 Apr 22.

PMID:
18691856
11.

Development of enteric submicron particle formulation of papain for oral delivery.

Sharma M, Sharma V, Panda AK, Majumdar DK.

Int J Nanomedicine. 2011;6:2097-111. doi: 10.2147/IJN.S23985. Epub 2011 Sep 23.

12.

Development of delayed-release proliposomes tablets for oral protein drug delivery.

Tantisripreecha C, Jaturanpinyo M, Panyarachun B, Sarisuta N.

Drug Dev Ind Pharm. 2012 Jun;38(6):718-27. doi: 10.3109/03639045.2011.623168. Epub 2011 Oct 15.

PMID:
21999514
13.

Ionotropically cross-linked pH-sensitive IPN hydrogel matrices as potential carriers for intestine-specific oral delivery of protein drugs.

El-Sherbiny IM, Salama A, Sarhan AA.

Drug Dev Ind Pharm. 2011 Feb;37(2):121-30. doi: 10.3109/03639045.2010.495754. Epub 2010 Jul 8.

PMID:
20615156
14.

pH-sensitive and mucoadhesive thiolated Eudragit-coated chitosan microspheres.

Quan JS, Jiang HL, Kim EM, Jeong HJ, Choi YJ, Guo DD, Yoo MK, Lee HG, Cho CS.

Int J Pharm. 2008 Jul 9;359(1-2):205-10. doi: 10.1016/j.ijpharm.2008.04.003. Epub 2008 Apr 12.

PMID:
18490120
15.

Design and evaluation of matrices of Eudragit with polycarbophil and carbopol for colon-specific delivery.

Asghar LF, Chandran S.

J Drug Target. 2008 Dec;16(10):741-57. doi: 10.1080/10611860802473345 .

PMID:
19005938
16.

Alginate/polymethacrylate copolymer microparticles for the intestinal delivery of enzymes.

Scocca S, Faustini M, Villani S, Munari E, Conte U, Russo V, Riccardi A, Vigo D, Torre ML.

Curr Drug Deliv. 2007 Apr;4(2):103-8.

PMID:
17456029
17.

pH-sensitive microparticles for oral drug delivery based on alginate/oligochitosan/Eudragit(®) L100-55 "sandwich" polyelectrolyte complex.

Calija B, Cekić N, Savić S, Daniels R, Marković B, Milić J.

Colloids Surf B Biointerfaces. 2013 Oct 1;110:395-402. doi: 10.1016/j.colsurfb.2013.05.016. Epub 2013 May 17.

PMID:
23751419
18.

Controlled release microspheres based on Eudragit L100 for the oral administration of erythromycin.

Morishita I, Morishita M, Machida Y, Nagai T.

Drug Des Deliv. 1991 Jul;7(4):309-19.

PMID:
1930622
19.

pH sensitive alginate-guar gum hydrogel for the controlled delivery of protein drugs.

George M, Abraham TE.

Int J Pharm. 2007 Apr 20;335(1-2):123-129. doi: 10.1016/j.ijpharm.2006.11.009. Epub 2006 Nov 7.

PMID:
17147980
20.

Genipin-crosslinked O-carboxymethyl chitosan-gum Arabic coacervate as a pH-sensitive delivery system and microstructure characterization.

Huang GQ, Cheng LY, Xiao JX, Wang SQ, Han XN.

J Biomater Appl. 2016 Aug;31(2):193-204. doi: 10.1177/0885328216651393. Epub 2016 May 26.

PMID:
27231264

Supplemental Content

Support Center